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1. Introduction
Neuro-trauma, stroke, and neuro-degenerative diseases are
accompanied by loss of nerve cells, axon degeneration, and
disrupted communication in neural networks. Developing new
therapies for treating neuro-degenerative diseases is an important
challenge (Okano et al., 2007). Current treatments options are
inadequate and do not provide sufﬁcient quality of life. One of the
promising cell therapy approaches to prevent secondary degen-
eration and support neuronal growth is neuro-transplantation of
embryonic stem cells pre-differentiated into neural progenitor
cells, and neural stem cells which are proposed as a source of new
glial and neural cells, and as a mean for delivering to the damaged
neural tissue of neuro-trophic factors supporting neuron survival,
axon growth and establishment of new inter-cellular contacts
(neuron–neuron, neuron–glia) (Liew et al., 2007; Lepore and
Neurochemistry International 53 (2008) 389–394
A R T I C L E I N F O
Article history:
Received 17 September 2008
Accepted 19 September 2008
Available online 26 September 2008
Keywords:
Amyotrophic lateral sclerosis




A B S T R A C T
Genetically modiﬁed mono-nuclear cell fraction from human umbilical cord blood (HUCB) expressing
human vascular endothelial growth factor (VEGF) and mouse neural L1 cell adhesion molecule (L1CAM)
were used for gene-stem cell therapy of transgenic G93A mice adopted as an animal amyotrophic lateral
sclerosis (ALS) model. We generated non-viral plasmid constructs, expressing human VEGF165 (pcDNA-
VEGF) and mouse neural L1 cell adhesion molecule (pcDNA-mL1CAM). Mono-nuclear fraction of HUCB
cells were transiently transfected by electro-poration with a mixture of expression plasmids (pcDNA-
VEGF + pcDNA-mL1CAM). Sixteen transgenic female and male mice were randomly assigned to three
groups: (1) transplantation of genetically modiﬁed HUCB cells expressing L1 and VEGF (n = 6), (2)
transplantation of un-transfected HUCB cells (n = 5), and (3) control group (n = 5). In ﬁrst two
experimental groups 1  106 cells were injected retro-orbitally in pre-symptomatic 22–25-week-old
G93A mice. Our results demonstrate that HUCB cells successfully grafted into nervous tissue of ALS mice
and survived for over 3 months. Therefore, genetically modiﬁed HUCB cells migrate in the spinal cord
parenchyma, proliferate, but instead of transforming into nerve cells, they differentiate into endothelial
cells forming new blood vessels. We propose that: (A) expression of mouse neural L1CAM is responsible
for increased homing and subsequent proliferation of transplanted cells at the site of neuro-degeneration,
(B) expression of human VEGF directs HUCB cell differentiation into endothelial cells, and (C) neuro-
protective effect may stem from the delivery of various neuro-trophic factors from newly formed blood
vessels.
 2008 Elsevier Ltd. All rights reserved.
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